Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A battle for your hair: herbal oil vs. minoxidil serum in a Head-to-Head trial

NCT ID NCT06552039

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial compares three approaches for people dealing with hair fall and premature graying: a polyherbal hair oil, a minoxidil 5% hair serum, and a combination of both. About 99 healthy adults aged 18 to 55 with noticeable hair fall will apply their assigned product to the scalp three times a week. Researchers will measure changes in hair thickness, density, growth rate, strength, and scalp health to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Polyherbal hair oil and a minoxidil 5% hair serum
What this could lead to
If successful, this could point toward a natural or combined approach to reduce hair fall, improve hair growth, and delay premature graying.
What could go wrong
This is an early, small study, so results may not apply broadly. Herbal products can vary in quality, and minoxidil may cause scalp irritation or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

99 people

The number who actually took part.

Started

Dec 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age: 18 to 55 years and above (both inclusive) at the time of consent. 2. Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females). 3. Females of childbearing potential must have a self-reported negative urine pregnancy. 4. Subject is in good general health as determined by the Investigator on the basis of medical history. 5. Female with 40-50 counts and male with 25 -30 counts of hair fall at screening. 6. Subject having AGA and premature Gray hair at a time of screening. 7. Subject having premature gray hair at a time of screening. 8. Subject with pro-claimed nonpathological thinning of hair. 9. Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study. 10. If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will beconsidered as non-childbearing potential if they are surgically sterile, have been post menopausal for at least 1 year or have had a tubal ligation. 11. Subjects are willing to give written informed consent and are willing to follow the study procedure. 12. Subjects who commit not to use any other medicated/ prescription shampoos/hair care products (containing Minoxidil), any other hair growth products or hair colour or dye, other than the test products for the entire duration of the study. 13. Willing to use test products throughout the study period. 14. Subject is willing and able to follow and allow study staff to performed study test methods. 15. Subject is willing and able to follow the study directions, to participate in the study, returning for all specified visits. 16. Subject must be able to understand and provide written informed consent to participate in the study Exclusion Criteria: 1. Subject have history of severe hair fall due to any clinically significant problems like anaemia, thyroid problems. 2. Subject have history of any dermatological condition of the scalp other than hair loss and dandruff. 3. Subject have history of any prior hair growth procedures (e.g. hair transplant or laser). 4. Subject who had taken topical treatment of hair loss for at least 4 weeks. 5. Subject who had taken any systemic treatment for at least 3 months. 6. History of alcohol or drug addiction. 7. Subject having history or resent condition of irritated or visibly inflamed scalp or severe scalp disease. 8. Subject having history or present condition of an allergic response to any cosmetic products, any other condition which could warrant exclusion from the study. 9. Pregnant or breast feeding or planning to become pregnant during the study period. 10. History of chronic illness which may influence the cutaneous state. 11. Subject have participated any clinical research study related to hair care products. 12. Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Androgenetic alopecia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NovoBliss Research Pvt Ltd

    Ahmedabad, Gujarat, 382481, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.